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Abstract
Objective: To compare the effectiveness of a physiotherapy programme with a control treatment of advice and education
in patients with neurogenic claudication symptoms.
Design: Pragmatic randomised controlled clinical trial.
Setting: Primary care-based musculoskeletal service.
Patients: Adults aged 50 or over with neurogenic claudication symptoms causing limitation of walking.
Interventions: Condition-specific home exercises combined with advice and education, or advice and education alone.
Main outcome measures: The primary outcome was the difference in improvement of symptom severity scores on the
Swiss Spinal Stenosis Scale at eight weeks. Secondary outcomes included measures of physical function, pain and general
well-being at eight weeks and 12 months.
Results: There was no significant difference between groups in the Swiss Spinal Stenosis symptom severity scale at eight
weeks (t = 0.47, p = 0.643): mean change (SD) control group 20.18 (0.47), treatment group 20.10 (0.66), difference (95% CI)
0.08 (20.19, 0.35); baseline-adjusted difference 0.06 (20.19, 0.31)]. An unplanned subgroup analysis suggested that for
patients with the top 25% of baseline symptom severity scores, the physiotherapy exercise programme resulted in an
improvement in the primary outcome, and modest but consistently better secondary outcomes at both time-points
compared to the control group. The effectiveness in different subgroups requires further direct evaluation.
Conclusions: In the treatment of patients with neurogenic claudication symptoms, a physiotherapist-prescribed home
exercise programme is no more effective than advice and education.
Ethical approval: The study was approved by Leeds Central Ethics Committee and informed consent was given by all
participating patients.
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Introduction
Patients with lumbar spinal stenosis (LSS) classically present
with symptoms of neurogenic claudication (NC); these symp-
toms are described as leg pain, numbness and heaviness brought
on by walking and relieved when the spine is flexed, for example
when stooping or sitting [1]. The symptoms of NC can cause
significant limitations in walking, requiring patients to seek
treatment for their symptoms [2]. Lumbar spinal stenosis is the
most common reason for spinal surgery in patients over the age
of 65, but as surgical outcomes are variable, conservative
treatment is generally recommended in the first instance and
the majority of patients are therefore referred for assessment
and treatment by physiotherapists at some point in the course of
the condition.
When patients with NC symptoms are referred for physiother-
apy treatment, they are commonly prescribed home exercise
programmes to include spinal flexion and stabilisation exercises in
addition to aerobic fitness exercises [3]. These exercise choices
reflect recommended programmes which are based on the
theoretical benefits of modifying posture to reduce the lordotic
curve and minimise the extension forces through the lumbar spine
and thereby optimising the available space for the spinal nerves
[4–7]. There is, however, little evidence from clinical trials
regarding effectiveness. It has been shown that lumbar posture can
be modified with exercises [8] and the few clinical trials of LSS
which have included exercise therapy as part of a package of
conservative treatments, suggest that exercise therapy consisting of
flexion-based spinal movements, lumbopelvic stabilisation and
posterior pelvic tilting exercises may be beneficial [9–11]. The
clinical effectiveness of such condition-specific exercise pro-
grammes when used as a primary care intervention has not, to-
date, been evaluated adequately.
The effects of exercise therapy on function and symptoms may
not be expected to match those for surgical interventions, but it is
known that the longer term results from surgery tend towards
deterioration and there are obvious inherent risks associated with
surgical treatments. It remains important, therefore, to establish
whether conservative treatments such as physiotherapy exercises
can offer an acceptable alternative in the management of NC. The
aim of this trial was to evaluate the effectiveness of a condition-
specific home exercise programme, focusing on posture modifica-
tion and aerobic fitness. Specifically, the trial was designed to
compare outcomes in measures of pain and function in people
with NC receiving a typical six-week, physiotherapist prescribed
home exercise programme, compared to a control group receiving
advice and education alone.
Methods
The study was submitted for review through IRAS, and was
approved by the Leeds Central Ethics Committee. A two-arm
randomised controlled trial design was used. The protocol for this
trial and supporting CONSORT checklist are available as
supporting information; see CONSORT checklist S1 and Protocol
S1. In this pragmatic trial, patients were recruited from general
practitioner referrals to the Leeds Musculoskeletal and Rehabil-
itation Service, a primary care-based musculoskeletal service.
Inclusion and exclusion criteria for recruitment to the study are
presented in Table 1. Severe cases of spinal stenosis (those with
acute cauda equina syndrome or worsening neurological status)
who were likely surgical candidates were excluded. Patients
recruited to the trial were therefore typical of patients with mild
to moderate LSS, who are commonly referred to primary care
services for physiotherapy treatment in the first instance. MRI
confirmation of lumbar spinal stenosis was not an inclusion
criterion for this study, as it was intended that the trial should focus
on the evaluation of a treatment for the clinical syndrome of NC as
currently recognised and treated by physiotherapists in the
primary care setting. Patients were included therefore on the
basis of symptoms on clinical assessment that were consistent with
NC and which would have entered them onto a primary care
physiotherapy intervention pathway in normal NHS practice.
After screening for eligibility, potential participants provided
informed written consent, and were then randomised to the
relevant treatment arm determined by random permuted block
randomisation (block sizes 2, 4 or 6) without stratification via a
commercial web-based computer-generated randomisation proto-
col. The block size was not revealed to the trial co-ordinator or
treating physiotherapists, and a sealed envelope system was used
by administrative support staff to conceal treatment allocation
from participants and physiotherapists until the first treatment
appointment. The trial co-ordinator remained blinded to the
treatment allocation until all final follow-up data was received and
collated. Statistical analysis was undertaken with the statistician
blind to treatment allocation.
Interventions
All interventions were delivered by a team of 28 senior
musculoskeletal physiotherapists working in the primary care
setting, who received specific training and a written manual before
the start of the trial. Participants randomised to the control group
received advice and education provided in both verbal and written
format (see Appendix S1) at the initial physiotherapy appointment
and were given a contact telephone number of the treating
physiotherapist for further contact and advice if needed during the
six week treatment period. Participants randomised to the active
Table 1. Inclusion and exclusion criteria.
Inclusion criteria Exclusion criteria
Age 50 years or over Cognitive impairment or other medical conditions preventing understanding or participation in
the study
Bilateral neurogenic claudication symptoms (ie exercise induced
leg pain on walking, relieved in sitting or flexion)
Clearly defined radicular symptoms (ie single nerve root symptoms)
Patient-reported limitation in walking tolerance due to
NC symptoms
Signs or symptoms of acute cauda equina syndrome or severe or worsening neurological status
requiring medical or surgical assessment. (This includes significant or worsening nerve root or
cauda equina function, significant or sinister weight loss, pyrexia, unremitting pain, significant
inflammatory joint disease)
doi:10.1371/journal.pone.0072878.t001
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treatment group received the same standardised advice and
education as the control group and in addition, they were
prescribed a condition-specific home exercise programme to be
carried out twice daily at home over a six week period. The set of
exercises was selected to reflect a combination of current
physiotherapy practice as evidenced by recent practitioner survey
data [3,12] and recommendations in the available literature [4–7].
The constituent exercises focussed on 1) flattening of the lumbar
lordosis 2) lumbar flexion 3) abdominal muscle activation 4) trunk
muscle strengthening and 5) aerobic fitness (see Appendix S2).
Participants were taught how to perform one of each of these five
types of exercise at their first physiotherapy appointment, and
were then instructed to perform the exercises at least twice daily
at home. Exercise technique, difficulty levels and number of
repetitions of each exercise were reviewed and progressed at
subsequent physiotherapy appointments, and adherence to the
home exercise programme throughout and after the six week
treatment period was encouraged by the treating physiotherapist.
As the structure of these interventions aimed to reflect typical
primary care management in current clinical practice, which
would generally consist of the provision of appropriate advice, and
the prescription of home exercises for self-management, compli-
ance was not formally evaluated. Any additional treatments
received during the trial period (e.g. walking aids, spinal injections)
were also documented.
Outcome measures
The primary measure of outcome was the change in the
symptom severity subscale score of the Swiss Spinal Stenosis (SSS)
scale [12] at eight weeks (two weeks after completion of the six
week treatment period). The symptom severity scale was felt to
best reflect changes important to patients with neurogenic
claudication symptoms seeking medical care. Secondary endpoints
included 8 week changes in the physical function subscale of the
SSS, the General Well-Being Index (GWBI) [13], Oswestry
disability questionnaire [14], and a visual analogue scale for back
pain and leg pain. The Hospital Anxiety and Depression Scale
(HADS) [15] was collected at baseline to investigate the potential
impact of psychological distress on improvements in patient-
reported pain and quality of life. All data for these outcomes were
collected via questionnaires completed by patients either in clinic
or at home, without guidance from the treating physiotherapist. In
addition, walking tolerance was measured using a shuttle walking
test (SWT), which has been shown to be a reliable and responsive
measure in patients receiving treatment for chronic spinal
problems, including LSS, and to correlate well with self-reported
functional walking items in outcome measures such as the EQ5D
and SF36 [16–18]. Whilst the SWT may not give a true reflection
of walking capacity in a patient’s normal environment, it is easy to
use in the clinical setting, requiring patients to walk up and down a
10 metre course at increasing speed for each minute, dictated by
signals from a pre-recorded audiotape, up to a maximum of 12
minutes (1020 metres). Evaluation of longer term outcomes was
based on postal questionnaire follow-up to measure changes at 12
months in all measures other than the shuttle walking test.
Sample size
The required sample size (n = 76) was determined a priori, based
on the ability to detect a difference (D) between the treatment
groups equivalent to the previously determined minimum
clinically important difference (MCID) of 0.5 points for the SSS
symptom severity scale [19], and assuming a standard deviation of
0.56 [20,21] with power set at 90% (alpha 5%), and allowing for a
drop-out rate of 20%.
Rasch-transformation of questionnaire data
To provide interval scaling, the ordinal data from each of the
questionnaires was transformed to interval scaling via Rasch
analysis using RUMM2030. All scales demonstrated adequate fit
to the Rasch model and strict unidimensionality [22] [SSS (Chi-
square 4.28, df 10, p = 0.934; 4.88% of independent t-tests
significant); Oswestry (Chi-square 23.92, df 14, p = 0.091; 2.96%
of independent t-tests significant); GWBI (Chi-square 2.81, df 4,
p = 0.590; 3.83% of independent t-tests significant)].
Statistical tests
Patients with data available at each endpoint were included in
the analyses according to their original treatment allocation.
Multiple imputation by chained equations was performed to
account for missing data; 20 imputed datasets were generated. The
imputation model included baseline data for all efficacy variables
in addition to exploratory confounders and auxiliary variables
found to be associated with the values of the outcome at Pearson’s
|r|$0.5. Binary logistic regression models of the probability that
data were missing at follow-up were created; variables found to be
associated with missingness at p,0.1 were also included as
auxiliary variables. Imputation was performed in each treatment
group separately to allow for interaction effects to be investigated.
Missing baseline data were handled using mean imputation which
has been recommended for randomised trials where there is a
need to limit the number of covariates in the imputation model
[23]. All efficacy outcomes were imputed using predictive mean
matching. Changes in the primary outcome measure (SSS
symptom severity score) and secondary and exploratory outcome
measures were computed passively and were initially explored
descriptively in each group. Subsequent inferential analysis of
these data used linear regression; each model included an
indicator variable denoting treatment, and the baseline values of
the dependent variable. Preliminary checks were conducted to
ensure that linear regression assumptions of normality and
homoscedasticity of residuals were not violated. Analyses were
repeated using robust quantile regression, which does not require
errors to be normally distributed or homoskedastic. Both
unadjusted and adjusted results are presented. Results from the
imputed datasets were combined using Rubin’s rules. Multiple
imputation assumes data are missing at random, i.e. the likelihood
that the data is missing does not depend on the value of the data
that is missing (for example, patients with more severe symptoms
being less likely to have complete severity data). As a sensitivity
analysis the values imputed were altered to reflect a situation in
which patients with missing data had improved or deteriorated,
either in both groups simultaneously or in one or the other group,
thus assuming the data were missing not at random. Additional
sensitivity analyses were undertaken where appropriate controlling
for imbalances between the treatment groups in other baseline
characteristics. A per protocol analysis was also performed which
included patients in the control arm who had received just one
physiotherapy session and patients in the active treatment arm
who had attended at least 3 physiotherapy sessions; we then
extended this to exclude patients who reported having had surgery
or injections to the spine during the course of the study. We also
performed a complete case analysis which included only those
patients with data available at each time-point. Because the use of
block randomisation could theoretically permit researchers to
subvert the allocation concealment for some patients, we used a
variety of methods to identify selection bias in our data. We
calculated P(E), the probability of being randomised to the
experimental (treatment) arm for each participant, based on
knowledge of their position within the randomisation block and
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knowledge of the groups to which preceding patients in the block
had been assigned [24]. To identify observed selection bias we
assessed the magnitude of the between-group differences at
baseline for patients where P(E)?0.5. To identify unobserved
selection bias, we included P(E) as a covariate in the analysis
models. All tests were two-tailed at the 0.05 level of significance;
corrections for multiple comparisons were made on a family-wise
basis for all secondary endpoint analyses using the Holm method.
The threshold for significance at the 5% level was consequently set
to p = 0.006 for the secondary endpoints. Exploratory endpoint
Figure 1. Flow chart of participants through trial.
doi:10.1371/journal.pone.0072878.g001
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analyses were not adjusted for multiple comparisons. Analyses
were performed in Stata 12.1.
Results
One hundred and six potential participants were screened over
a 17 month enrolment period, resulting in 76 recruits to the trial.
Forty were female, with a mean age in the sample of 73 years (SD
8.7 years), a mean baseline symptom severity score of 3.05 (SD
0.61), physical function score 2.36 (SD 0.50) and mean number of
10 metre walking test shuttles 22.15 (SD 18.15). Follow-up data
were available for 71 (93%) participants at 8 week follow-up and
61 (80%) participants at 12 months (see flow-chart Figure 1).
Missing data
The level of missing data at the primary endpoint was below
10% in each group and where data were missing this was generally
due to reasons considered to be unrelated to the patients’ health
(see flow-chart Figure 1). The pattern of missing data was deemed
arbitrary rather than monotone; 3 patients who did not attend for
follow-up at 8 weeks nevertheless returned the 12 month
questionnaires. Mean imputation was used for missing baseline
covariates because the missing indicator method caused colinearity
problems with the imputation model; mean imputation has been
recommended where there is a need to limit the number of
covariates in the imputation model [23]. Age, gender and
symptom duration were included in the imputation model because
these variables were to be included in sensitivity analyses. No
further auxiliary variables were identified (data not shown). Monte
Carlo errors for the regression coefficients, t-statistics and p-values
were adequate according to published guidelines [25], indicating
that 20 imputations were sufficient to achieve stable results.
The baseline characteristics of each group are presented in
Table 2. Although MRI confirmation of LSS was not specified as
an inclusion criterion, 43 of the 76 participants reported at the
time of recruitment that they had undergone a previous MRI scan
of the spine and the radiologist reports were traced and reviewed
where available. Of the thirty-seven MRI reports which could be
obtained (48.7% of all participants), all confirmed the presence of
LSS, supporting the clinical diagnosis of this condition by
musculoskeletal physiotherapists in the primary care clinical
setting. The treatment groups were generally well balanced in
most baseline demographic and clinical characteristics, however
patients in the control group were on average five years younger,
fewer were female, and they had experienced symptoms for
longer.
Testing for observable selection bias at baseline
Although some differences were observed between the rando-
mised groups at baseline (Table 2), these were not in a consistent
direction. Controls were younger, a smaller proportion of the
group was female, they had symptoms of longer duration, and they
completed more shuttles. There were no substantive differences in
any of the patient-reported outcomes and in particular the groups
were very well matched in terms of SSS symptom severity (3.3 vs.
3.2). Restricting the analysis to patients in whom P(E)?0.5 yielded
differences of equal or reduced magnitude for the majority of
outcomes (Table S1).
Primary outcome
One patient in the active therapy arm performed the shuttle test
at week 8 but did not complete any of the questionnaires; therefore
change in SSS symptom severity at eight weeks was available for
36 patients in the control arm and 34 in the active treatment arm.
Multiple imputation allowed all 38 patients in each group to be
included in the analysis. Mean (SD) unadjusted change in SSS
symptom severity at eight weeks was 20.18 (0.47) in the control
arm and 20.10 (0.66) in the active treatment arm [unadjusted
mean (95% CI) between-group difference 0.07 (20.18, 0.32);
baseline-adjusted difference 0.05 (20.19, 0.29)]. The primary
analysis showed no significant difference between the groups
(t = 0.42, p = 0.676). Subsequent analysis investigating effect
modification indicated that interpretation of the main effects in
the adjusted analysis was complicated by an interaction between
baseline symptom severity and score changes in the treatment
group (t = 23.84, p,0.001), such that participants in the active
treatment group with relatively low baseline symptom severity
scores deteriorated, and those with higher baseline scores generally
Table 2. Baseline characteristics.
Control n = 38 Active n = 38
Age, years: mean (SD), range 70.8 (8.3), 53 to 87 75.3 (8.6), 54 to 86
Female: n (%) 18 (47.4%) 22 (57.9%)
BMI: mean (SD), range 28.10 (4.34), 20.8 to 37.1 (n = 36) 28.30 (5.32), 22.5 to 49.2 (n = 35)
Duration*, years: median (IQR) 10.0 (2.8 to 35.8) 3.5 (1.0 to 10.0)
Spinal MRI report available 23 (60.5%) 20 (52.6%)
SSS symptom: mean (SD) 3.3 (0.5) 3.2 (0.6)
SSS physical: mean (SD) 2.6 (0.4) 2.2 (0.4)
Shuttles completed: median (IQR) 21.0 (12.0 to 34.5) 15.0 (5.5 to 27.5) (n = 37)
Oswestry score: mean (SD) 43.4 (9.5) 42.1 (7.7)
General Well-Being Index: mean (SD) 65.68 (14.44) 67.26 (11.60) (n = 35)
Back pain VAS: mean (SD) 63.2 (29.4) 55.2 (29.6) (n = 37)
Leg pain VAS: mean (SD) 67.6 (22.8) 64.5 (30.0) (n = 36)
HADS depression: mean (SD) 9.0 (3.2) 9.3 (2.4) (n = 37)
N physio sessions: median (IQR), range 1 (1 to 1), 0 to 2 3 (2 to 3), 0 to 4 (n = 36)
*Time since onset of first symptom (back and/or leg pain).
doi:10.1371/journal.pone.0072878.t002
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improved, whereas for subjects in the control arm, baseline values
had little influence over the degree of change observed (Figure 2
shows change in SSS symptom severity score at eight weeks
plotted against baseline values in the control group [circles; dotted
line] and treatment group [crosses; solid line]).
The efficacy of the treatment appeared, therefore, to vary with
the level of pre-treatment symptom severity. A number of
unplanned analyses were therefore conducted to control for this
interaction. Firstly, the interaction was assumed to be a genuine
property of the relationship between treatment and symptom
severity and so to help quantify the interaction effect the mean
change in each treatment group at different baseline levels of
symptom severity was estimated from the regression equation:
Change in SSS symptom severity~{0:50z0:10xz2:80y0:85xy
where x is baseline SSS symptom severity, y = 0 for control group,
y = 1 for active group.
Estimated changes for the minimum and maximum, upper and
lower quartiles and median of the distribution of baseline values
are presented in Table 3. The predicted values indicated a
between group difference for baseline symptom severity scores at
or above the 75th percentile.
Secondly, it was assumed that the interaction between treatment
and symptom severity may be a manifestation of regression to the
mean, which was more apparent in the treatment group due to a
greater spread of values at the extremes of the scale. When the
analysis was restricted to people with a narrower range of baseline
values (between the 5th and 95th percentiles of the distribution [2.5
and 4 respectively]: control group n = 35; treatment group n = 33),
this eliminated the interaction (t = 21.44, p = 0.156) and there was
no difference in SSS symptom severity at eight weeks between
groups [mean control group 20.16, treatment group 20.03;
baseline-adjusted mean between-group difference (95% CI) 0.11
(20.13, 0.34), t = 0.91, p = 0.366). If the assumption is accepted
that group differences in score changes are simply due to
regression to the mean, these outcomes indicate that the exercise
treatment provided no benefit over advice and education alone.
Neither the sensitivity analysis controlling for age, sex and disease
duration nor the per protocol analyses showed substantively
different results (data not shown). Adjusting the imputation to
Figure 2. Change in SSS symptom severity score at eight weeks plotted against baseline values in the control group (circles; dotted
line) and treatment group (crosses; solid line).
doi:10.1371/journal.pone.0072878.g002
Table 3. Predicted values of the primary outcome, change in SSS symptom severity score at eight weeks, at varying levels of
baseline SSS symptom severity.
Baseline-adjusted change at 8 weeks
SSS symptom severity
at baseline Control n = 38 Active n = 38 Difference (95% CI)
Minimum ( = 1.90) 20.31 0.88 1.19 (0.56, 1.81)
25th percentile ( = 2.96) 20.20 0.08 0.29 (0.04, 0.53)
Mean ( = 3.22) 20.18 20.12 0.06 (20.15, 0.28)
75th percentile ( = 3.57) 20.14 20.38 20.23 (20.50, 0.03)
Maximum ( = 4.71) 0.03 21.23 21.20 (21.89, 20.51)
doi:10.1371/journal.pone.0072878.t003
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reflect the best-case scenario under a situation in which the data
were not missing at random, i.e. all missing values in the treatment
arm set to zero and all missing values in the control arm set to the
maximum possible score, did not yield a statistically significant
difference between the groups in the primary analysis [adjusted
mean difference 20.39 (20.81, 0.03), t = 21.86, p = 0.066].
Secondary outcomes
No substantive or statistically significant differences between
treatment groups were identified for the secondary or exploratory
outcomes at eight weeks or 12 months, with the possible exception
of walking tolerance (number of shuttles) at eight weeks (Table 4;
Table S2). When all subjects were included in the shuttle test
Table 4. Changes in secondary and exploratory outcomes at eight weeks and 12 months – unadjusted values and baseline-
adjusted results.
Outcome Mean change Mean (95% CI) difference between groups Linear regression
Control (n = 38) Active (n = 38) Unadjusted Adjusted
At 8 weeks
SSS physical function* 20.11 20.08 0.03 (20.18, 0.23) 0.01 (20.19, 0.22) t = 0.15, p = 0.882
N shuttles completed** 20.12 3.31 3.44 (24.20, 11.07) 1.27 (26.76, 9.31) t = 0.32, p = 0.751
N shuttles completed#
(excluding 2 outliers)
21.34 4.43 5.77 (21.32, 12.86) 4.14 (23.63, 11.91) t = 1.08, p = 0.287
Oswestry 21.00 20.14 0.86 (23.07, 4.79) 0.56 (23.35, 4.47) t = 0.29, p = 0.776
General Well-Being Index 0.16 20.08 20.24 (26.42, 5.94) 0.38 (25.32, 6.08) t = 0.13, p = 0.893
Back pain VAS 211.44 21.91 9.52 (25.37, 24.42) 5.12 (27.94, 18.19) t = 0.78, p = 0.436
Leg pain VAS 29.58 24.85 4.73 (29.90, 19.36) 3.58 (210.42, 17.58) t = 0.51, p = 0.609
At 12 months
SSS symptom severity 20.43 20.08 0.35 (20.06, 0.75) 0.31 (20.07, 0.71) t = 1.67, p = 0.102
SSS physical function* 20.20 20.07 0.13 (20.21, 0.46) 0.11 (20.22, 0.44) t = 0.69, p = 0.491
Oswestry 23.77 21.27 2.50 (25.35, 10.36) 2.19 (25.56, 9.95) t = 0.57, p = 0.572
General Well-Being Index 1.88 21.09 22.97 (212.53, 6.58) 22.26 (211.35, 6.84) t = –0.51, p = 0.614
Back pain VAS 212.40 20.88 11.52 (27.39, 30.43) 7.27 (210.28, 24.82) t = 0.84, p = 0.407
Leg pain VAS 218.63 23.79 14.84 (27.96, 37.63) 12.83 (28.42, 34.08) t = 1.24, p = 0.226
Values are mean (95% CI) unless otherwise stated.
*Residuals show slight deviations from normal.
**Residuals not normally distributed.
#Residuals normally distributed.
doi:10.1371/journal.pone.0072878.t004
Table 5. Changes in secondary and exploratory outcomes in a subgroup of patients with symptom severity scores exceeding the
75th percentile at baseline.
Outcome Mean change Mean (90% CI) difference between groups
Control (n = 10) Active (n = 11) Unadjusted Adjusted
At 8 weeks
SSS physical function 0.00 20.23 20.24 (20.52, 0.05) 20.25 (20.54, 0.05)
N shuttles completed 20.11 5.88 5.99 (29.59, 21.56) 5.03 (29.07, 19.14)
Oswestry 1.09 22.53 23.62 (210.59, 3.34) 24.48 (29.84, 0.88)
General Well-Being Index 0.44 24.59 25.03 (217.10, 7.04) 22.73 (214.07, 8.61)
Back pain VAS 222.45 21.55 20.90 (28.68, 50.49) 8.50 (223.34, 40.34)
Leg pain VAS 212.12 221.00 28.89 (236.21, 18.45) 28.95 (236.86, 18.97)
At 12 months
SSS symptom severity 20.67 20.72 20.06 (20.85, 0.73) 20.12 (20.78, 0.75)
SSS physical function 20.20 20.47 20.27 (21.00, 0.46) 20.30 (21.04, 0.45)
Oswestry 24.60 210.94 26.35 (223.39, 10.70) 26.98 (223.89, 9.93)
General Well-Being Index 1.55 213.83 215.38 (237.83, 7.07) 211.44 (233.37, 10.49)
Back pain VAS 216.65 24.28 12.36 (235.42, 60.14) 29.52 (259.74, 40.70)
Leg pain VAS 216.63 215.08 1.55 (250.40, 53.50) 22.19 (247.30, 51.67)
doi:10.1371/journal.pone.0072878.t005
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linear regression analysis at week 8 the residuals were not normally
distributed. When two subjects who were clinical outliers were
excluded, (one control subject with an existing foot problem at
baseline whose test performance had improved dramatically at
eight weeks, another randomised to the active treatment arm
whose performance had dramatically declined without a corre-
sponding increase in pain or function), the distribution of the
residuals improved and the between-group difference increased.
Repeating the comparison with quantile regression, which is
robust to outliers and does not require residuals to be normally
distributed, allowed all subjects to be included and yielded a
difference of similar magnitude [adjusted median difference 6.44
(0.33, 12.55), t = 2.11, p = 0.039]. However, following correction
for multiplicity this was not statistically significant. Adjusting for
the additional variables, including HADS, did not affect our
conclusions regarding the other secondary outcomes.
Testing for unobservable selection bias
Despite finding no evidence of observable selection bias in the
baseline measurements, it is still possible that unobservable
selection bias could affect the outcome. When the probability of
assignment to the treatment group was included as a covariate in
the primary analysis this did not affect the magnitude of the
between-group difference [0.03 (20.27, 0.33), t = 0.21, p = 0.831]
and P(E) was not substantively associated with the outcome [0.05
(20.45, 0.54), t = 0.19, p = 0.849]. We similarly found no evidence
of selection bias in the secondary outcomes (data not shown).
To further investigate whether patients in our sample with
relatively higher symptom severity scores than others may have
responded to the intervention, we repeated the secondary analyses
in a subgroup of patients with baseline symptom severity scores at
or above the 75th percentile (control n = 10, treatment group
n = 11). Whilst the mean changes were consistently in favour of the
treatment group at both time-points with the exception of back
pain VAS at week 8, the between-group differences were modest
(Table 5).
No adverse events were reported by any participants during the
trial period.
Discussion
The results of this trial indicate that the self-directed
programme of flexion and aerobic type exercises delivered in this
study did not systematically improve symptom severity in a typical
group of primary care-based NHS patients, either in the short
term or long term. For the primary outcome of SSS symptom
severity at eight weeks, there was no substantive difference
between the two groups in the majority of the study population.
There was, however, some evidence that for those with higher
baseline scores for symptom severity, the physiotherapy exercise
programme resulted in an improvement in SSS scores at 8 week
follow-up (Table 3). This may have been due to regression to the
mean; excluding patients with baseline scores at the extremes of
the distribution served to eliminate the interaction and no
substantive treatment effect was identified in the remaining
patients. In the patients whose baseline symptom severity scores
were at or above the 75th percentile, mean improvement in all
secondary outcomes at eight weeks except the back pain VAS was
greater in the exercise treatment subgroup than the control
subgroup, although the differences were modest (see Table 4).
These unplanned exploratory analyses might indicate that an
exercise programme may have a beneficial effect in patients with
more severe symptoms, although further trials would be needed to
explore this explicitly.
Limitations of study
Because baseline symptom severity score was found to interact
with the magnitude and direction of the treatment effect,
assessment of the efficacy of the intervention was complicated.
Reasons for the interaction were, however, explored using
unplanned subgroup analyses and estimates of the treatment
effect for a variety of baseline scores were calculated to aid
interpretation. The use of block randomisation could conceivably
have allowed the allocation concealment to be subverted, however
we found no evidence that this had happened. A further criticism
could be that the effect of greater physiotherapy contact in the
active treatment group was not controlled for. However, the
design of this trial is pragmatic, and it is therefore accepted that
part of any therapeutic effect in the exercise group might be
derived from the greater therapist contact and support [26].
Results in context
Up to six contact appointments for each patient in the
intervention group were allowed for in the trial protocol, but in
practice adhesion to the protocol appointment schedule was poor.
Patients receiving the exercise programme treatment in fact
received a mean of just three treatment appointments, reflecting
current pressures on NHS clinicians to minimise treatment contact
times. Whilst designed as a pragmatic study, this low level of
supervision for the home exercise programme may have adversely
affected the trial outcomes. Providing some insight into the
importance of intensity of intervention, one recently published trial
[26] used a similar exercise programme, but delivered it as an
intensive and supervised intervention; participants in the exercise
groups attended a rehabilitation department to carry out exercises
5 days a week over a 3 week period. This trial reported that
Oswestry Disability Index scores, measured treadmill walking
tolerance, and visual analogue scores for back and leg pain all
improved significantly in two groups receiving this intensive
exercise therapy protocol compared to a control group. Although
the trial was limited by its smaller sample size (n = 45), these results
might suggest that in order to be effective, an exercise programme
may need to be intensive and supervised. As has been shown in
other degenerative conditions [27], the current trend of reducing
physiotherapy contact times in the NHS in response to compe-
tition and cost-cutting pressures may reduce the resulting benefit
of otherwise potentially effective physiotherapy treatments to
below efficacious levels.
Conclusions
The home exercise programme in this trial, which was based on
current clinical physiotherapy practice, did not yield any
systematic improvement in symptoms or function. Exploratory
subgroup analysis suggested that exercises may be beneficial in
patients with more severe symptoms, although this may simply
represent a regression to the mean. Therefore, the effectiveness in
different subgroups requires further direct evaluation.
Clinical implications
Based on the results of this trial, an outpatient prescribed, home
exercise programme cannot be recommended as an effective
treatment for neurogenic claudication, especially in mild to
moderate cases. Education and advice on self-management may
be adequate for NC patients with mild symptoms, as there was no
deterioration observed over time in the control group. For more
severely symptomatic patients, future research should include an
evaluation of whether an exercise programme needs to be
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intensive and supervised in order to produce clinical benefits
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